MedTrace Logo

Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica

NCT04004052 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2020-02-20

No results posted yet for this study

Summary

Meralgia paresthetica (MP) is an entrapment mononeuropathy of the lateral femoral cutaneous nerve (LFCN), where conservative treatment options are not always sufficient.

The aim of this study was to evaluate the efficacy of ultrasound (US) guided lateral femoral cutaneous nerve injection in the management of meralgia paresthetica by comparing with transcutaneous electrical nerve stimulation (TENS) therapy and sham transcutaneous electrical nerve stimulation therapy.

Conditions

  • Meralgia Paresthetica

Interventions

OTHER

Ultrasound guided injection

OTHER

Transcutaneous Electrical Nerve Stimulation (TENS)

OTHER

Sham Transcutaneous Electrical Nerve Stimulation (TENS)

Sponsors & Collaborators

  • Fatih Sultan Mehmet Training and Research Hospital

    lead OTHER

Principal Investigators

  • Gülcan Öztürk, MD · Fatih Sultan Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
42 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2015-01-01
Completion
2015-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04004052 on ClinicalTrials.gov